Evidence map›Paper›PMID 27872261›Full record

ArticleSchizophrenia bulletin2018

Comorbid Diabetes and Depression in a National Sample of Adults With Psychosis.

Debra L Foley, Andrew Mackinnon, Vera A Morgan, David J Castle, Anna Waterreus, Cherrie A Galletly

Abstract read
In one paragraph

Article in Schizophrenia bulletin, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Synergistic Anti-inflammatory and Neuroprotective Effects ofFrontiers in cell and developmental biology · 2021
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Debra L FoleyCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.
Andrew MackinnonBlack Dog Institute, University of New South Wales, Sydney, Australia.
Vera A MorganNeuropsychiatric Epidemiology Research unit, School of Psychiatry and Clinical Neurosciences, University of Western Australia, Perth, Australia.
David J CastleSt Vincent's Hospital, Melbourne & Department of Psychiatry, University of Melbourne, Melbourne, Australia.
Anna WaterreusNeuropsychiatric Epidemiology Research unit, School of Psychiatry and Clinical Neurosciences, University of Western Australia, Perth, Australia.
Cherrie A GalletlyDiscipline of Psychiatry, University of Adelaide, Adelaide, Australia.

Funding

NICHD NIH HHS N01 AA021004
6 · The paper itself

Abstract

Objective: People with psychosis have an elevated risk of depression and diabetes but no large-scale study has characterized their relationship. We aimed to assess this association and to evaluate possible explanatory factors. Methods: Analysis of cross-sectional data from a national sample of 1155 people with psychosis who gave a fasting blood sample and could be tested for diabetes mellitus. The association between current diabetes mellitus and current depression was estimated using logistic regression, adjusted for age, sex and current psychotropic medication. Results: A diagnosis of depression was significantly associated with diabetes (OR = 2.16, P = .048) and diabetes medication (OR = 2.50, P = .050) in people with schizophrenia but no other psychosis subtype. Adjustment for cognitive processing speed and current residence (especially psychiatric hospitalization) attenuated that association to nonsignificance. Diabetes and diabetes medication were not significantly associated with antidepressant or mood stabilizer medication. Conclusions: Clinicians should be aware that people with schizophrenia and diabetes have twice the rate of current depression, and that comorbid diabetes and depression is associated with cognitive impairment and hospitalization. Efforts to disentangle the causal pathways between diabetes, depression, and cognition in people with schizophrenia may be complicated by multiple indications in people with psychosis for the prescription of depression medication, and their lack of association with diabetes mellitus.

Indexed as

AdolescentAdultAustraliaCognitive DysfunctionComorbidityCross-Sectional StudiesDepressionDepressive DisorderDiabetes MellitusFemaleHospitalizationHumansMaleMiddle AgedPsychotic DisordersSchizophreniacognitive impairmentdepressive symptomsdiabetes-related disabilityhospitalizationschizophrenia

Identifiers

PMID27872261
PMCPMC5767947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.